While it is unlikely that the identified EXOSC mutations drive the multiple myeloma disease, our study here clearly shows that these mutations have in vivo consequences for the conserved and essential RNA exosome-Mtr4 interaction. This evidence concerns the gene MTREX and plasma cell myeloma.